Summary

The global Drug Delivery System in Vivo market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Drug Delivery System (DDS) refers to a technical system that comprehensively regulates the distribution of drugs in the body in terms of space, time and dosage. Its goal is to deliver the right amount of drugs to the right location at the right time, thereby increasing drug utilization efficiency, improving efficacy, reducing costs, and reducing side effects.
In 2025, the North America Drug Delivery System in Vivo market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of Drug Delivery System in Vivo include Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi, Pfizer, Takeda, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Drug Delivery System in Vivo market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
Covis Pharma
AbbVie
Dr Reddy
AstraZeneca
Aspen Pharmacare
Acrotech Biopharma
TWi Pharmaceuticals(Bora Pharma)
Segment by Type
Carrier Formulation Delivery
Targeted Delivery
Segment by Application
Small Molecule Drug
Proteins and Peptides
Antibody
Nucleic Acids
Others
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Drug Delivery System in Vivo sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Drug Delivery System in Vivo manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Drug Delivery System in Vivo product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Drug Delivery System in Vivo value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Drug Delivery System in Vivo Product Scope
1.2 Drug Delivery System in Vivo by Type
1.2.1 Global Drug Delivery System in Vivo Sales by Type (2021, 2025 & 2032)
1.2.2 Carrier Formulation Delivery
1.2.3 Targeted Delivery
1.3 Drug Delivery System in Vivo by Application
1.3.1 Global Drug Delivery System in Vivo Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Small Molecule Drug
1.3.3 Proteins and Peptides
1.3.4 Antibody
1.3.5 Nucleic Acids
1.3.6 Others
1.4 Global Drug Delivery System in Vivo Market Estimates and Forecasts (2021-2032)
1.4.1 Global Drug Delivery System in Vivo Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Drug Delivery System in Vivo Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Drug Delivery System in Vivo Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Drug Delivery System in Vivo Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Drug Delivery System in Vivo Historical Market Scenario by Region (2021-2026)
2.2.1 Global Drug Delivery System in Vivo Sales Market Share by Region (2021-2026)
2.2.2 Global Drug Delivery System in Vivo Revenue Market Share by Region (2021-2026)
2.3 Global Drug Delivery System in Vivo Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Drug Delivery System in Vivo Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Drug Delivery System in Vivo Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Drug Delivery System in Vivo Market Size and Prospects (2021-2032)
2.4.2 Europe Drug Delivery System in Vivo Market Size and Prospects (2021-2032)
2.4.3 China Drug Delivery System in Vivo Market Size and Prospects (2021-2032)
2.4.4 Japan Drug Delivery System in Vivo Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Drug Delivery System in Vivo Historical Market Review by Type (2021-2026)
3.1.1 Global Drug Delivery System in Vivo Sales by Type (2021-2026)
3.1.2 Global Drug Delivery System in Vivo Revenue by Type (2021-2026)
3.1.3 Global Drug Delivery System in Vivo Average Price by Type (2021-2026)
3.2 Global Drug Delivery System in Vivo Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Drug Delivery System in Vivo Sales Forecast by Type (2027-2032)
3.2.2 Global Drug Delivery System in Vivo Revenue Forecast by Type (2027-2032)
3.2.3 Global Drug Delivery System in Vivo Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Drug Delivery System in Vivo
4 Global Market Size by Application
4.1 Global Drug Delivery System in Vivo Historical Market Review by Application (2021-2026)
4.1.1 Global Drug Delivery System in Vivo Sales by Application (2021-2026)
4.1.2 Global Drug Delivery System in Vivo Revenue by Application (2021-2026)
4.1.3 Global Drug Delivery System in Vivo Average Price by Application (2021-2026)
4.2 Global Drug Delivery System in Vivo Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Drug Delivery System in Vivo Sales Forecast by Application (2027-2032)
4.2.2 Global Drug Delivery System in Vivo Revenue Forecast by Application (2027-2032)
4.2.3 Global Drug Delivery System in Vivo Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Drug Delivery System in Vivo Applications
5 Competition Landscape by Players
5.1 Global Drug Delivery System in Vivo Sales by Player (2021-2026)
5.2 Global Top Drug Delivery System in Vivo Players by Revenue (2021-2026)
5.3 Global Drug Delivery System in Vivo Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Drug Delivery System in Vivo revenue as of 2025
5.4 Global Drug Delivery System in Vivo Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Drug Delivery System in Vivo, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Drug Delivery System in Vivo, Product Type & Application
5.7 Global Key Manufacturers of Drug Delivery System in Vivo, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Drug Delivery System in Vivo Sales by Company
6.1.1.1 North America Drug Delivery System in Vivo Sales by Company (2021-2026)
6.1.1.2 North America Drug Delivery System in Vivo Revenue by Company (2021-2026)
6.1.2 North America Drug Delivery System in Vivo Sales Breakdown by Type (2021-2026)
6.1.3 North America Drug Delivery System in Vivo Sales Breakdown by Application (2021-2026)
6.1.4 North America Drug Delivery System in Vivo Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Drug Delivery System in Vivo Sales by Company
6.2.1.1 Europe Drug Delivery System in Vivo Sales by Company (2021-2026)
6.2.1.2 Europe Drug Delivery System in Vivo Revenue by Company (2021-2026)
6.2.2 Europe Drug Delivery System in Vivo Sales Breakdown by Type (2021-2026)
6.2.3 Europe Drug Delivery System in Vivo Sales Breakdown by Application (2021-2026)
6.2.4 Europe Drug Delivery System in Vivo Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Drug Delivery System in Vivo Sales by Company
6.3.1.1 China Drug Delivery System in Vivo Sales by Company (2021-2026)
6.3.1.2 China Drug Delivery System in Vivo Revenue by Company (2021-2026)
6.3.2 China Drug Delivery System in Vivo Sales Breakdown by Type (2021-2026)
6.3.3 China Drug Delivery System in Vivo Sales Breakdown by Application (2021-2026)
6.3.4 China Drug Delivery System in Vivo Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Drug Delivery System in Vivo Sales by Company
6.4.1.1 Japan Drug Delivery System in Vivo Sales by Company (2021-2026)
6.4.1.2 Japan Drug Delivery System in Vivo Revenue by Company (2021-2026)
6.4.2 Japan Drug Delivery System in Vivo Sales Breakdown by Type (2021-2026)
6.4.3 Japan Drug Delivery System in Vivo Sales Breakdown by Application (2021-2026)
6.4.4 Japan Drug Delivery System in Vivo Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Amgen
7.1.1 Amgen Company Information
7.1.2 Amgen Business Overview
7.1.3 Amgen Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Amgen Drug Delivery System in Vivo Products Offered
7.1.5 Amgen Recent Development
7.2 Teva
7.2.1 Teva Company Information
7.2.2 Teva Business Overview
7.2.3 Teva Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Teva Drug Delivery System in Vivo Products Offered
7.2.5 Teva Recent Development
7.3 Roche
7.3.1 Roche Company Information
7.3.2 Roche Business Overview
7.3.3 Roche Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Roche Drug Delivery System in Vivo Products Offered
7.3.5 Roche Recent Development
7.4 UCB (Union Chimique Belge)
7.4.1 UCB (Union Chimique Belge) Company Information
7.4.2 UCB (Union Chimique Belge) Business Overview
7.4.3 UCB (Union Chimique Belge) Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.4.4 UCB (Union Chimique Belge) Drug Delivery System in Vivo Products Offered
7.4.5 UCB (Union Chimique Belge) Recent Development
7.5 Celgene
7.5.1 Celgene Company Information
7.5.2 Celgene Business Overview
7.5.3 Celgene Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Celgene Drug Delivery System in Vivo Products Offered
7.5.5 Celgene Recent Development
7.6 Merck
7.6.1 Merck Company Information
7.6.2 Merck Business Overview
7.6.3 Merck Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Merck Drug Delivery System in Vivo Products Offered
7.6.5 Merck Recent Development
7.7 Gilead Sciences
7.7.1 Gilead Sciences Company Information
7.7.2 Gilead Sciences Business Overview
7.7.3 Gilead Sciences Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Gilead Sciences Drug Delivery System in Vivo Products Offered
7.7.5 Gilead Sciences Recent Development
7.8 Sanofi
7.8.1 Sanofi Company Information
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Sanofi Drug Delivery System in Vivo Products Offered
7.8.5 Sanofi Recent Development
7.9 Pfizer
7.9.1 Pfizer Company Information
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Pfizer Drug Delivery System in Vivo Products Offered
7.9.5 Pfizer Recent Development
7.10 Takeda
7.10.1 Takeda Company Information
7.10.2 Takeda Business Overview
7.10.3 Takeda Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Takeda Drug Delivery System in Vivo Products Offered
7.10.5 Takeda Recent Development
7.11 Bausch&Lomb
7.11.1 Bausch&Lomb Company Information
7.11.2 Bausch&Lomb Business Overview
7.11.3 Bausch&Lomb Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Bausch&Lomb Drug Delivery System in Vivo Products Offered
7.11.5 Bausch&Lomb Recent Development
7.12 Samyang Biopharmaceuticals
7.12.1 Samyang Biopharmaceuticals Company Information
7.12.2 Samyang Biopharmaceuticals Business Overview
7.12.3 Samyang Biopharmaceuticals Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Samyang Biopharmaceuticals Drug Delivery System in Vivo Products Offered
7.12.5 Samyang Biopharmaceuticals Recent Development
7.13 Johnson & Johnson
7.13.1 Johnson & Johnson Company Information
7.13.2 Johnson & Johnson Business Overview
7.13.3 Johnson & Johnson Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Johnson & Johnson Drug Delivery System in Vivo Products Offered
7.13.5 Johnson & Johnson Recent Development
7.14 TOLMAR
7.14.1 TOLMAR Company Information
7.14.2 TOLMAR Business Overview
7.14.3 TOLMAR Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.14.4 TOLMAR Drug Delivery System in Vivo Products Offered
7.14.5 TOLMAR Recent Development
7.15 Astellas
7.15.1 Astellas Company Information
7.15.2 Astellas Business Overview
7.15.3 Astellas Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.15.4 Astellas Drug Delivery System in Vivo Products Offered
7.15.5 Astellas Recent Development
7.16 Covis Pharma
7.16.1 Covis Pharma Company Information
7.16.2 Covis Pharma Business Overview
7.16.3 Covis Pharma Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.16.4 Covis Pharma Drug Delivery System in Vivo Products Offered
7.16.5 Covis Pharma Recent Development
7.17 AbbVie
7.17.1 AbbVie Company Information
7.17.2 AbbVie Business Overview
7.17.3 AbbVie Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.17.4 AbbVie Drug Delivery System in Vivo Products Offered
7.17.5 AbbVie Recent Development
7.18 Dr Reddy
7.18.1 Dr Reddy Company Information
7.18.2 Dr Reddy Business Overview
7.18.3 Dr Reddy Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.18.4 Dr Reddy Drug Delivery System in Vivo Products Offered
7.18.5 Dr Reddy Recent Development
7.19 AstraZeneca
7.19.1 AstraZeneca Company Information
7.19.2 AstraZeneca Business Overview
7.19.3 AstraZeneca Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.19.4 AstraZeneca Drug Delivery System in Vivo Products Offered
7.19.5 AstraZeneca Recent Development
7.20 Aspen Pharmacare
7.20.1 Aspen Pharmacare Company Information
7.20.2 Aspen Pharmacare Business Overview
7.20.3 Aspen Pharmacare Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.20.4 Aspen Pharmacare Drug Delivery System in Vivo Products Offered
7.20.5 Aspen Pharmacare Recent Development
7.21 Acrotech Biopharma
7.21.1 Acrotech Biopharma Company Information
7.21.2 Acrotech Biopharma Business Overview
7.21.3 Acrotech Biopharma Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.21.4 Acrotech Biopharma Drug Delivery System in Vivo Products Offered
7.21.5 Acrotech Biopharma Recent Development
7.22 TWi Pharmaceuticals(Bora Pharma)
7.22.1 TWi Pharmaceuticals(Bora Pharma) Company Information
7.22.2 TWi Pharmaceuticals(Bora Pharma) Business Overview
7.22.3 TWi Pharmaceuticals(Bora Pharma) Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2021-2026)
7.22.4 TWi Pharmaceuticals(Bora Pharma) Drug Delivery System in Vivo Products Offered
7.22.5 TWi Pharmaceuticals(Bora Pharma) Recent Development
8 Drug Delivery System in Vivo Manufacturing Cost Analysis
8.1 Drug Delivery System in Vivo Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Drug Delivery System in Vivo
8.4 Drug Delivery System in Vivo Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Drug Delivery System in Vivo Distributors List
9.3 Drug Delivery System in Vivo Customers
10 Drug Delivery System in Vivo Market Dynamics
10.1 Drug Delivery System in Vivo Industry Trends
10.2 Drug Delivery System in Vivo Market Drivers
10.3 Drug Delivery System in Vivo Market Challenges
10.4 Drug Delivery System in Vivo Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Drug Delivery System in Vivo Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
Table 2. Global Drug Delivery System in Vivo Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
Table 3. Global Market Drug Delivery System in Vivo Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Table 4. Global Drug Delivery System in Vivo Sales (K Units) by Region (2021-2026)
Table 5. Global Drug Delivery System in Vivo Sales Market Share by Region (2021-2026)
Table 6. Global Drug Delivery System in Vivo Revenue (US$ Million) Market Share by Region (2021-2026)
Table 7. Global Drug Delivery System in Vivo Revenue Share by Region (2021-2026)
Table 8. Global Drug Delivery System in Vivo Sales (K Units) Forecast by Region (2027-2032)
Table 9. Global Drug Delivery System in Vivo Sales Market Share Forecast by Region (2027-2032)
Table 10. Global Drug Delivery System in Vivo Revenue (US$ Million) Forecast by Region (2027-2032)
Table 11. Global Drug Delivery System in Vivo Revenue Share Forecast by Region (2027-2032)
Table 12. Global Drug Delivery System in Vivo Sales by Type (K Units) & (2021-2026)
Table 13. Global Drug Delivery System in Vivo Sales Share by Type (2021-2026)
Table 14. Global Drug Delivery System in Vivo Revenue by Type (US$ Million) & (2021-2026)
Table 15. Global Drug Delivery System in Vivo Average Price by Type (US$/Unit) & (2021-2026)
Table 16. Global Drug Delivery System in Vivo Sales by Type (K Units) & (2027-2032)
Table 17. Global Drug Delivery System in Vivo Revenue by Type (US$ Million) & (2027-2032)
Table 18. Global Drug Delivery System in Vivo Average Price by Type (US$/Unit) & (2027-2032)
Table 19. Representative Players of Each Type
Table 20. Global Drug Delivery System in Vivo Sales by Application (K Units) & (2021-2026)
Table 21. Global Drug Delivery System in Vivo Sales Share by Application (2021-2026)
Table 22. Global Drug Delivery System in Vivo Revenue by Application (US$ Million) & (2021-2026)
Table 23. Global Drug Delivery System in Vivo Average Price by Application (US$/Unit) & (2021-2026)
Table 24. Global Drug Delivery System in Vivo Sales by Application (K Units) & (2027-2032)
Table 25. Global Drug Delivery System in Vivo Revenue Market Share by Application (US$ Million) & (2027-2032)
Table 26. Global Drug Delivery System in Vivo Average Price by Application (US$/Unit) & (2027-2032)
Table 27. New Sources of Growth in Drug Delivery System in Vivo Applications
Table 28. Global Drug Delivery System in Vivo Sales by Company (K Units) & (2021-2026)
Table 29. Global Drug Delivery System in Vivo Sales Share by Company (2021-2026)
Table 30. Global Drug Delivery System in Vivo Revenue by Company (US$ Million) & (2021-2026)
Table 31. Global Drug Delivery System in Vivo Revenue Share by Company (2021-2026)
Table 32. Global Drug Delivery System in Vivo by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery System in Vivo as of 2025)
Table 33. Global Market Drug Delivery System in Vivo Average Price by Company (US$/Unit) & (2021-2026)
Table 34. Global Key Manufacturers of Drug Delivery System in Vivo, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Drug Delivery System in Vivo, Product Type & Application
Table 36. Global Key Manufacturers of Drug Delivery System in Vivo, Date of Entry into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Drug Delivery System in Vivo Sales by Company (2021-2026) & (K Units)
Table 39. North America Drug Delivery System in Vivo Sales Market Share by Company (2021-2026)
Table 40. North America Drug Delivery System in Vivo Revenue by Company (2021-2026) & (US$ Million)
Table 41. North America Drug Delivery System in Vivo Revenue Market Share by Company (2021-2026)
Table 42. North America Drug Delivery System in Vivo Sales by Type (2021-2026) & (K Units)
Table 43. North America Drug Delivery System in Vivo Sales Market Share by Type (2021-2026)
Table 44. North America Drug Delivery System in Vivo Sales by Application (2021-2026) & (K Units)
Table 45. North America Drug Delivery System in Vivo Sales Market Share by Application (2021-2026)
Table 46. Europe Drug Delivery System in Vivo Sales by Company (2021-2026) & (K Units)
Table 47. Europe Drug Delivery System in Vivo Sales Market Share by Company (2021-2026)
Table 48. Europe Drug Delivery System in Vivo Revenue by Company (2021-2026) & (US$ Million)
Table 49. Europe Drug Delivery System in Vivo Revenue Market Share by Company (2021-2026)
Table 50. Europe Drug Delivery System in Vivo Sales by Type (2021-2026) & (K Units)
Table 51. Europe Drug Delivery System in Vivo Sales Market Share by Type (2021-2026)
Table 52. Europe Drug Delivery System in Vivo Sales by Application (2021-2026) & (K Units)
Table 53. Europe Drug Delivery System in Vivo Sales Market Share by Application (2021-2026)
Table 54. China Drug Delivery System in Vivo Sales by Company (2021-2026) & (K Units)
Table 55. China Drug Delivery System in Vivo Sales Market Share by Company (2021-2026)
Table 56. China Drug Delivery System in Vivo Revenue by Company (2021-2026) & (US$ Million)
Table 57. China Drug Delivery System in Vivo Revenue Market Share by Company (2021-2026)
Table 58. China Drug Delivery System in Vivo Sales by Type (2021-2026) & (K Units)
Table 59. China Drug Delivery System in Vivo Sales Market Share by Type (2021-2026)
Table 60. China Drug Delivery System in Vivo Sales by Application (2021-2026) & (K Units)
Table 61. China Drug Delivery System in Vivo Sales Market Share by Application (2021-2026)
Table 62. Japan Drug Delivery System in Vivo Sales by Company (2021-2026) & (K Units)
Table 63. Japan Drug Delivery System in Vivo Sales Market Share by Company (2021-2026)
Table 64. Japan Drug Delivery System in Vivo Revenue by Company (2021-2026) & (US$ Million)
Table 65. Japan Drug Delivery System in Vivo Revenue Market Share by Company (2021-2026)
Table 66. Japan Drug Delivery System in Vivo Sales by Type (2021-2026) & (K Units)
Table 67. Japan Drug Delivery System in Vivo Sales Market Share by Type (2021-2026)
Table 68. Japan Drug Delivery System in Vivo Sales by Application (2021-2026) & (K Units)
Table 69. Japan Drug Delivery System in Vivo Sales Market Share by Application (2021-2026)
Table 70. Amgen Company Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 73. Amgen Drug Delivery System in Vivo Product
Table 74. Amgen Recent Development
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Teva Drug Delivery System in Vivo Product
Table 79. Teva Recent Development
Table 80. Roche Company Information
Table 81. Roche Description and Business Overview
Table 82. Roche Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Roche Drug Delivery System in Vivo Product
Table 84. Roche Recent Development
Table 85. UCB (Union Chimique Belge) Company Information
Table 86. UCB (Union Chimique Belge) Description and Business Overview
Table 87. UCB (Union Chimique Belge) Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. UCB (Union Chimique Belge) Drug Delivery System in Vivo Product
Table 89. UCB (Union Chimique Belge) Recent Development
Table 90. Celgene Company Information
Table 91. Celgene Description and Business Overview
Table 92. Celgene Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Celgene Drug Delivery System in Vivo Product
Table 94. Celgene Recent Development
Table 95. Merck Company Information
Table 96. Merck Description and Business Overview
Table 97. Merck Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Merck Drug Delivery System in Vivo Product
Table 99. Merck Recent Development
Table 100. Gilead Sciences Company Information
Table 101. Gilead Sciences Description and Business Overview
Table 102. Gilead Sciences Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Gilead Sciences Drug Delivery System in Vivo Product
Table 104. Gilead Sciences Recent Development
Table 105. Sanofi Company Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Sanofi Drug Delivery System in Vivo Product
Table 109. Sanofi Recent Development
Table 110. Pfizer Company Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Pfizer Drug Delivery System in Vivo Product
Table 114. Pfizer Recent Development
Table 115. Takeda Company Information
Table 116. Takeda Description and Business Overview
Table 117. Takeda Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Takeda Drug Delivery System in Vivo Product
Table 119. Takeda Recent Development
Table 120. Bausch&Lomb Company Information
Table 121. Bausch&Lomb Description and Business Overview
Table 122. Bausch&Lomb Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Bausch&Lomb Drug Delivery System in Vivo Product
Table 124. Bausch&Lomb Recent Development
Table 125. Samyang Biopharmaceuticals Company Information
Table 126. Samyang Biopharmaceuticals Description and Business Overview
Table 127. Samyang Biopharmaceuticals Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Samyang Biopharmaceuticals Drug Delivery System in Vivo Product
Table 129. Samyang Biopharmaceuticals Recent Development
Table 130. Johnson & Johnson Company Information
Table 131. Johnson & Johnson Description and Business Overview
Table 132. Johnson & Johnson Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Johnson & Johnson Drug Delivery System in Vivo Product
Table 134. Johnson & Johnson Recent Development
Table 135. TOLMAR Company Information
Table 136. TOLMAR Description and Business Overview
Table 137. TOLMAR Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. TOLMAR Drug Delivery System in Vivo Product
Table 139. TOLMAR Recent Development
Table 140. Astellas Company Information
Table 141. Astellas Description and Business Overview
Table 142. Astellas Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Astellas Drug Delivery System in Vivo Product
Table 144. Astellas Recent Development
Table 145. Covis Pharma Company Information
Table 146. Covis Pharma Description and Business Overview
Table 147. Covis Pharma Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Covis Pharma Drug Delivery System in Vivo Product
Table 149. Covis Pharma Recent Development
Table 150. AbbVie Company Information
Table 151. AbbVie Description and Business Overview
Table 152. AbbVie Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. AbbVie Drug Delivery System in Vivo Product
Table 154. AbbVie Recent Development
Table 155. Dr Reddy Company Information
Table 156. Dr Reddy Description and Business Overview
Table 157. Dr Reddy Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Dr Reddy Drug Delivery System in Vivo Product
Table 159. Dr Reddy Recent Development
Table 160. AstraZeneca Company Information
Table 161. AstraZeneca Description and Business Overview
Table 162. AstraZeneca Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. AstraZeneca Drug Delivery System in Vivo Product
Table 164. AstraZeneca Recent Development
Table 165. Aspen Pharmacare Company Information
Table 166. Aspen Pharmacare Description and Business Overview
Table 167. Aspen Pharmacare Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Aspen Pharmacare Drug Delivery System in Vivo Product
Table 169. Aspen Pharmacare Recent Development
Table 170. Acrotech Biopharma Company Information
Table 171. Acrotech Biopharma Description and Business Overview
Table 172. Acrotech Biopharma Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. Acrotech Biopharma Drug Delivery System in Vivo Product
Table 174. Acrotech Biopharma Recent Development
Table 175. TWi Pharmaceuticals(Bora Pharma) Company Information
Table 176. TWi Pharmaceuticals(Bora Pharma) Description and Business Overview
Table 177. TWi Pharmaceuticals(Bora Pharma) Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. TWi Pharmaceuticals(Bora Pharma) Drug Delivery System in Vivo Product
Table 179. TWi Pharmaceuticals(Bora Pharma) Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Drug Delivery System in Vivo Distributors List
Table 183. Drug Delivery System in Vivo Customers List
Table 184. Drug Delivery System in Vivo Market Trends
Table 185. Drug Delivery System in Vivo Market Drivers
Table 186. Drug Delivery System in Vivo Market Challenges
Table 187. Drug Delivery System in Vivo Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources


List of Figures
Figure 1. Drug Delivery System in Vivo Product Picture
Figure 2. Global Drug Delivery System in Vivo Sales (US$ Million) by Type (2021, 2025 & 2032)
Figure 3. Global Drug Delivery System in Vivo Sales Market Share by Type in 2025 & 2032
Figure 4. Carrier Formulation Delivery Product Picture
Figure 5. Targeted Delivery Product Picture
Figure 6. Global Drug Delivery System in Vivo Sales (US$ Million) by Application (2021, 2025 & 2032)
Figure 7. Global Drug Delivery System in Vivo Sales Market Share by Application in 2025 & 2032
Figure 8. Small Molecule Drug Examples
Figure 9. Proteins and Peptides Examples
Figure 10. Antibody Examples
Figure 11. Nucleic Acids Examples
Figure 12. Others Examples
Figure 13. Global Drug Delivery System in Vivo Sales, (US$ Million), 2021 VS 2025 VS 2032
Figure 14. Global Drug Delivery System in Vivo Sales Growth Rate (2021-2032) & (US$ Million)
Figure 15. Global Drug Delivery System in Vivo Sales (K Units) Growth Rate (2021-2032)
Figure 16. Global Drug Delivery System in Vivo Price Trends Growth Rate (2021-2032) & (US$/Unit)
Figure 17. Drug Delivery System in Vivo Report Years Considered
Figure 18. Global Market Drug Delivery System in Vivo Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Figure 19. Global Drug Delivery System in Vivo Revenue Market Share by Region: 2021 VS 2025
Figure 20. North America Drug Delivery System in Vivo Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. North America Drug Delivery System in Vivo Sales (K Units) Growth Rate (2021-2032)
Figure 22. Europe Drug Delivery System in Vivo Revenue (US$ Million) Growth Rate (2021-2032)
Figure 23. Europe Drug Delivery System in Vivo Sales (K Units) Growth Rate (2021-2032)
Figure 24. China Drug Delivery System in Vivo Revenue (US$ Million) Growth Rate (2021-2032)
Figure 25. China Drug Delivery System in Vivo Sales (K Units) Growth Rate (2021-2032)
Figure 26. Japan Drug Delivery System in Vivo Revenue (US$ Million) Growth Rate (2021-2032)
Figure 27. Japan Drug Delivery System in Vivo Sales (K Units) Growth Rate (2021-2032)
Figure 28. Global Drug Delivery System in Vivo Revenue Share by Type (2021-2026)
Figure 29. Global Drug Delivery System in Vivo Sales Share by Type (2027-2032)
Figure 30. Global Drug Delivery System in Vivo Revenue Share by Type (2027-2032)
Figure 31. Global Drug Delivery System in Vivo Revenue Share by Application (2021-2026)
Figure 32. Global Drug Delivery System in Vivo Revenue Market Share by Application in 2021 & 2025
Figure 33. Global Drug Delivery System in Vivo Sales Share by Application (2027-2032)
Figure 34. Global Drug Delivery System in Vivo Revenue Share by Application (2027-2032)
Figure 35. Global Drug Delivery System in Vivo Sales Share by Company (2025)
Figure 36. Global Drug Delivery System in Vivo Revenue Share by Company (2025)
Figure 37. Global 5 Largest Drug Delivery System in Vivo Players Market Share by Revenue in Drug Delivery System in Vivo: 2021 & 2025
Figure 38. Drug Delivery System in Vivo Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 39. Manufacturing Cost Structure of Drug Delivery System in Vivo
Figure 40. Manufacturing Process Analysis of Drug Delivery System in Vivo
Figure 41. Drug Delivery System in Vivo Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed